From GUSTO to TIMI to BARC

Tsung-Ying Tsai; Mick Renkens; Bo Wang; Scot Garg; Davide Capodanno; Dominick J. Angiolillo; Yoshinobu Onuma; Patrick W. Serruys

doi:10.1007/978-3-031-87302-7_3

Article2025

Long-term visit-to-visit blood pressure variability and risk of cardiovascular and bleeding events: insights from the ENGAGE AF-TIMI 48 trial

Riccardo Proietti, Michael Palazzolo, Christian T. Ruff, Professor Gregory Lip, Robert P. Giugliano

Article2021

Abstract 9396: Evaluation of the ABC Pathway for Comprehensive Management of Atrial Fibrillation in 20,933 Patients from the ENGAGE AF-TIMI 48 Trial

Siddharth M. Patel, Sabina A. Murphy, Elliott M. Antman, Eugene Braunwald, Professor Gregory Lip, Robert P. Giugliano, Christian T. Ruff

Article2022

Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial

Siddharth M. Patel, Michael G. Palazzolo, Sabina A. Murphy, Elliot M. Antman, Eugene Braunwald, Hans‐Joachim Lanz, Professor Gregory Lip, Robert P. Giugliano, Christian T. Ruff

Article2018

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

Daniele Pastori, José Miguel Rivera‐Caravaca, María Asunción Esteve‐Pastor, Vanessa Roldán, Francisco Marı́n, Pasquale Pignatelli, Francesco Violi, Professor Gregory Lip

Article2017

Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED

José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor, Mariano Valdés, Vicente Vicente, Francisco Marı́n, Professor Gregory Lip

From GUSTO to TIMI to BARC

Discussion(0)

Related publications

Long-term visit-to-visit blood pressure variability and risk of cardiovascular and bleeding events: insights from the ENGAGE AF-TIMI 48 trial

Abstract 9396: Evaluation of the ABC Pathway for Comprehensive Management of Atrial Fibrillation in 20,933 Patients from the ENGAGE AF-TIMI 48 Trial

Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED